Mark is a Partner in Osborne Clarke's corporate team and Financial Services sector teams.
Mark is a highly experienced corporate lawyer, regularly advising on a broad range of matters including business strategy, M&A, takeovers, IPOs, fundraising, joint ventures, restructuring and corporate governance. The matters Mark advises on are frequently strategically important and/or complex, often cross-border.
Mark's clients range from large institutions and listed businesses through to funds/investors, scale-ups and successful entrepreneurs.
Mark has broad experience across a number of industry sectors but has particular experience and focus in the Financial Services and FinTech sectors, as well as TMT / Tech, Media and Comms.
Mark has been at Osborne Clarke since 2008. Prior to that he worked at Slaughter and May in London, with a period working in New York.
London & Country Mortgages
Sale of a 25% stake in the UK's leading independent mortgage broker, London & Country Mortgages (L&C), to Experian plc.
Hargreaves Lansdown plc
Rectification of unlawful dividends paid by FTSE100 UK leading investment platform Hargreaves Lansdown plc.
FeverTree Drinks plc
£158m AIM IPO of FeverTree Drinks plc.
Computershare
Acquisition by Computershare of international share schemes business Equatex from private equity firm Montagu.
Tribal Group plc
£60m rescue rights issue and disposal of Synergy business for software business Tribal Group plc.
PTC
£50m acquisition by PTC of software business Atego Systems Limited
The UNITE Group plc
£85m retail bond issue for The UNITE Group plc.
UNITE
Advised on FTSE-250 listed company UNITE's debut retail bond issue.
UNITE
Advised on their debut retail bond issue
Seven Technologies
Advised on its £7m takeover of AIM listed Datong, leading provider of intelligence equipment and solutions, creating one of the sectors largest independent specialist technology engineering businesses
Clydesdale Bank
Advised Clydesdale Bank Corporate & Structured Finance on its funding of a merger between two leading speciality pharmaceutical companies. The bank has agreed a £16m senior funding package to support IS Pharma plc and Sinclair Pharma plc, which are planning to join forces to create Sinclair IS Pharma plc, a substantial, fully integrated pan-European speciality pharmaceutical business
The Wealth Preservation Fund Plc
Advised on its formation and the arrangements between it and its co-sponsors.
PTC
Advised on its $50m acquisition of Atego, a developer of model-based systems and software engineering applications
Actual Experience plc
Advised Actual Experience plc on £16m share placing from new and existing shareholders
Empresaria Group
Advised Empresaria, an international specialist staffing group, on the £3.3m accelerated bookbuild used to part finance the acquisition of US healthcare recruiter PS.
Insights
New corporate governance codes usher in change for AIM and UK-listed companies
FCA publishes details of the new UK equity listing regime
Corporate governance code for London Stock Exchange's AIM set for further update
The code has guided small and mid-sized quoted companies in improving their corporate governance practices and reporting
Employee incentives: new opportunities for fintech companies
Digital Transformation Projects | The Legal Angles
Regulatory Outlook | May 2022
Regulatory Outlook | April 2022
Regulatory Outlook | March 2022
Are you ready for mandatory TCFD reporting in the UK?
UK government sets out plans for new prospectus regime
Regulatory Outlook | January 2022
CMA's FinTech focus continues
Crowdfunding platforms merger is abandoned following the Competition and Markets Authority's (CMA) adverse provisional findings.